New Weight-Loss drug shows promise in phase 2 trial
NCT ID NCT06124807
First seen Apr 24, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tested a new medication called Mazdutide to help adults with obesity or overweight manage their weight. About 179 participants took the drug or a placebo for 62 weeks to see how much weight they lost. The goal was to find out if the drug is safe and effective for weight control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington, 98801, United States
-
Charter Research - Lady Lake
The Villages, Florida, 32162, United States
-
Charter Research - Winter Park
Orlando, Florida, 32803, United States
-
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, 66606, United States
-
Dent Neurologic Institute
Amherst, New York, 14226, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois, 60640, United States
-
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, 60640, United States
-
Headlands Research - Scottsdale
Scottsdale, Arizona, 85260, United States
-
IMA Clinical Research Austin
Austin, Texas, 78745, United States
-
Knownwell
Needham, Massachusetts, 02492, United States
-
L-MARC Research Center
Louisville, Kentucky, 40213, United States
-
Las Vegas Medical Research
Las Vegas, Nevada, 89128, United States
-
Lucas Research, Inc.
New Bern, North Carolina, 28562, United States
-
North Suffolk Neurology
Port Jefferson Station, New York, 11776, United States
-
Northeast Research Institute (NERI)
Fleming Island, Florida, 32003, United States
-
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii, 96817, United States
-
Peninsula Research Associates
Rolling Hills Estates, California, 90274, United States
-
PlanIt Research, PLLC
Houston, Texas, 77079, United States
-
Quality Medical Research
Nashville, Tennessee, 37211, United States
-
Spectrum Medical, Inc.
Danville, Virginia, 24541, United States
-
StudyMetrix Research
City of Saint Peters, Missouri, 63303, United States
-
Suncoast Clinical Research, Inc.
New Port Richey, Florida, 34652, United States
-
Tekton Research - Fredericksburg Road
San Antonio, Texas, 78229, United States
-
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona, 85225, United States
-
The Institute for Liver Health II dba Arizona Liver Health-Tucson
Tucson, Arizona, 85712, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Huntington Park
Huntington Park, California, 90255, United States
Conditions
Explore the condition pages connected to this study.